Ahpra registration PHY0002298174
How these guides are written and reviewed →
Acute pulmonary oedema is a sudden build-up of fluid in the lungs, most often because the heart is not pumping effectively enough and pressure backs up into the lung circulation. It causes severe, rapid-onset breathlessness and is a medical emergency needing urgent treatment, usually in hospital. It is most often a complication of heart failure or another acute cardiac problem, and treating the underlying cause is central to both emergency care and preventing it happening again.
Definition
Acute pulmonary oedema is the rapid accumulation of fluid in the lung interstitium and alveoli. Most commonly it results from acutely raised pressure in the pulmonary capillaries because the left side of the heart cannot clear the blood returning to it — cardiogenic pulmonary oedema. It presents as sudden, severe breathlessness and is a medical emergency. The less common non-cardiogenic form, in which the capillary membrane itself is injured, is acute respiratory distress syndrome and is managed quite differently.1
Pathophysiology
Why fluid enters the lung
When the left ventricle cannot pump effectively — from acute myocardial injury, poorly controlled hypertension, valve disease or worsening chronic heart failure — pressure rises in the left atrium and then the pulmonary veins and capillaries. Once hydrostatic pressure exceeds the opposing oncotic pressure and the drainage capacity of the pulmonary lymphatics, fluid is forced into the interstitium and then into the alveoli themselves.
The effect on breathing
Interstitial fluid stiffens the lung and stimulates juxtacapillary receptors, producing rapid shallow breathing before any alveolar flooding occurs. Once fluid reaches the alveoli it dilutes surfactant and blocks gas exchange, causing hypoxaemia that worsens on lying flat as fluid redistributes. Compliance falls, the work of breathing rises steeply, and the respiratory muscles begin to fatigue.
Why it escalates so quickly
Hypoxaemia and the distress of air hunger drive a sympathetic surge that raises heart rate, blood pressure and afterload — which further impairs the failing ventricle and raises capillary pressure again. Negative intrathoracic pressure generated by laboured breathing increases venous return and left ventricular afterload, adding to the load. This self-reinforcing spiral is why the condition can go from breathlessness to respiratory failure within an hour, and why interrupting it — with positive pressure and vasodilatation — works so dramatically.
Flash pulmonary oedema
A distinct pattern in which severe hypertension, often with renal artery stenosis or diastolic dysfunction, produces abrupt oedema in a patient who was well an hour earlier and is frequently not fluid-overloaded at all. It responds to vasodilatation and afterload reduction rather than large doses of diuretic, which is a common and consequential misjudgement.
Co-morbidities
Acute pulmonary oedema most often occurs against a background of known or previously undiagnosed heart failure, coronary artery disease or recent myocardial infarction, hypertension, and valvular heart disease, particularly mitral or aortic disease. Chronic kidney disease, anaemia, atrial fibrillation, diabetes, obesity, obstructive sleep apnoea and COPD are all common and each complicates both diagnosis and treatment — COPD especially, since wheeze in acute pulmonary oedema is frequently misread as an asthma or COPD exacerbation and treated accordingly.
Prevalence
Acute pulmonary oedema is one of the most common cardiac emergencies presenting to hospital, tied closely to the high and rising prevalence of heart failure in an ageing population. It accounts for a substantial proportion of acute heart failure admissions in Australia and can also be the first presentation of previously unrecognised heart disease — roughly a fifth of patients have no prior cardiac diagnosis.
Causes and risk factors
- Acute myocardial infarction or ischaemia, suddenly impairing pump function or causing acute mitral regurgitation.
- Decompensated chronic heart failure, triggered by infection, dietary salt or fluid excess, missed medication, arrhythmia, anaemia or another intercurrent illness.
- Severe uncontrolled hypertension — flash pulmonary oedema.
- New atrial fibrillation or another tachyarrhythmia, which shortens diastolic filling time and abolishes the atrial contribution to filling.
- Acute valve dysfunction, such as chordal rupture causing sudden severe mitral regurgitation, or prosthetic valve failure.
- Fluid overload in kidney disease, dialysis non-attendance or excessive intravenous fluids.
- Medications — non-steroidal anti-inflammatories, some calcium channel blockers, corticosteroids and thiazolidinediones can all precipitate decompensation.
Symptoms
Typical features
Sudden, severe breathlessness that is markedly worse lying flat and relieved by sitting upright, with a sense of suffocation, anxiety and impending doom, cough, sweating, cool clammy skin and a rapid heart rate. Widespread crackles are heard, and in severe cases the patient coughs pink, frothy sputum.
Preceding warning signs
In decompensating chronic heart failure there is often a build-up over days: increasing ankle swelling, rapid weight gain, waking breathless at night (paroxysmal nocturnal dyspnoea), needing more pillows, reduced exercise tolerance and abdominal fullness. Recognising this window is what allows treatment before the emergency.
Cardiac asthma — a diagnostic trap
Wheeze from peribronchial oedema and airway compression is common and readily mistaken for asthma or a COPD exacerbation, particularly in older patients who have both. Treating cardiogenic pulmonary oedema with bronchodilators and steroids alone loses critical time.
Warning signs
Diagnosis
Why diagnosis matters
Treatment is time-critical and differs entirely from that of the conditions it mimics. Distinguishing cardiogenic pulmonary oedema from an asthma or COPD exacerbation, pneumonia, pulmonary embolism and ARDS determines whether the patient receives diuretics, nitrates and positive pressure, or bronchodilators, antibiotics or anticoagulation. Identifying the precipitant is equally important, since it determines whether the episode recurs next month.2
How is it diagnosed?
Diagnosis is largely clinical — the abrupt orthopnoeic breathlessness, crackles, elevated jugular venous pressure and often a third heart sound — and treatment begins before confirmation. Investigations then support the diagnosis and identify the cause.
Radiology
Chest X-ray shows upper-lobe venous diversion, interstitial changes with Kerley B lines, perihilar bat-wing alveolar shadowing, pleural effusions and often cardiomegaly. Radiographic change lags the clinical picture in both directions. Lung ultrasound is faster and more sensitive at the bedside, with bilateral B-lines distinguishing cardiogenic oedema from COPD exacerbation within minutes.
Blood tests and ECG
BNP or NT-proBNP is elevated in cardiac causes and is most useful for its high negative predictive value — a normal level makes cardiogenic oedema unlikely. Troponin identifies myocardial infarction as the trigger. An ECG looks for ischaemia, infarction, arrhythmia and left ventricular hypertrophy. Renal function, electrolytes, full blood count and blood gases complete the acute panel.
Echocardiography
Once stabilised, echocardiography identifies the underlying cardiac cause: systolic or diastolic dysfunction, valve disease, regional wall motion abnormality, or a mechanical complication of infarction. It is what converts an episode of pulmonary oedema into a specific, treatable diagnosis, and no patient should be discharged without a plan for it.
Investigations for related conditions
Assessment covers the precipitant — infection, anaemia, thyroid dysfunction, renal impairment, medication non-adherence — and screens for sleep-disordered breathing, which is common in heart failure and independently worsens outcomes. Where hypertension is severe and oedema recurrent, renal artery stenosis is considered.
Management
Management and goals
The immediate goals are to relieve hypoxaemia, reduce the work of breathing, offload the failing ventricle, and treat the precipitant. The subsequent goal — equally important and more often neglected — is to optimise long-term heart failure therapy so it does not happen again.
Immediate measures
Sit the person upright with legs dependent; this alone reduces venous return and improves lung mechanics and is the first step anyone present can take. High-flow oxygen is given for hypoxaemia, titrated to target saturation. Continuous monitoring of oxygen saturation, blood pressure, heart rhythm and urine output is established.
Non-invasive ventilation
Positive airway pressure is the intervention that changes the trajectory fastest. It recruits flooded alveoli, reduces the work of breathing, and lowers both venous return and left ventricular afterload. A Cochrane review found non-invasive ventilation — CPAP or bilevel — reduced hospital mortality and the need for intubation in cardiogenic pulmonary oedema.3 The large 3CPO trial found no mortality difference between CPAP, bilevel ventilation and standard oxygen therapy, but confirmed faster resolution of breathlessness, acidosis and hypercapnia with non-invasive ventilation.4 International guidelines recommend it in acute cardiogenic pulmonary oedema.5
Drug treatment in the acute phase
Intravenous loop diuretics relieve congestion in the fluid-overloaded patient. Nitrates reduce preload and, at higher doses, afterload, and are particularly effective in hypertensive flash pulmonary oedema where the problem is distribution rather than total volume. Inotropes and vasopressors are reserved for cardiogenic shock, and mechanical support for refractory cases.
Treating the precipitant
Reperfusion for myocardial infarction, rate or rhythm control for arrhythmia, blood pressure control in hypertensive crisis, antibiotics for infection, dialysis for fluid overload in renal failure, and surgical or transcatheter intervention for acute valve failure. An episode without an identified and corrected precipitant will recur.
After stabilisation
Attention turns to establishing or optimising guideline-directed heart failure therapy, correcting anaemia and iron deficiency, reviewing medications that precipitated the episode, and arranging echocardiography, cardiac rehabilitation and structured follow-up. The days after an admission are the highest-risk period for readmission and the highest-value window for intervention.
Medications
Medications in the acute episode
Intravenous loop diuretics, nitrates, and oxygen as required; opioids are now used sparingly, as observational data associate them with worse outcomes. Bronchodilators are avoided unless coexisting airways disease is genuinely present, since tachycardia is unhelpful in a failing ventricle.
Long-term heart failure therapy
Preventing recurrence depends on guideline-directed therapy for the underlying heart failure — typically an ACE inhibitor or angiotensin receptor–neprilysin inhibitor, a beta-blocker, a mineralocorticoid receptor antagonist and an SGLT2 inhibitor in reduced ejection fraction — titrated to target doses. Diuretics control symptoms but do not alter prognosis; the prognostic drugs are the others, and getting them to target dose is what prevents the next admission.
Medications to use with caution
Non-steroidal anti-inflammatories cause salt and water retention and blunt diuretic response; some calcium channel blockers are negatively inotropic; corticosteroids and thiazolidinediones promote fluid retention. A medication review is part of preventing recurrence, and patients should be told which over-the-counter analgesics to avoid.
Living with the risk of recurrence
Daily weight monitoring
The single most useful self-management task. Weighing at the same time each morning after voiding, recording it, and acting on a gain of two kilograms over two to three days — usually by contacting the heart failure service or following an agreed diuretic adjustment plan — catches decompensation days before breathlessness appears.
Fluid and salt
Individualised fluid restriction where advised, and reduction of dietary sodium, which is mostly hidden in processed food rather than added at the table. Practical, specific advice about which foods carry the salt is far more effective than an instruction to reduce it.
Recognising early warning signs
Increasing ankle or abdominal swelling, waking breathless at night, needing extra pillows, reduced exercise tolerance, persistent cough when lying down, and rapid weight gain. A written action plan naming these signs and the response to each is standard care.
Medication adherence and review
Missed doses are among the commonest precipitants. Dose administration aids, simplified regimens and honest conversations about side effects — particularly the diuretic-related urinary urgency that leads people to skip doses before going out — all improve adherence more than repetition does.
Exercise and rehabilitation
Exercise is safe and beneficial in stable heart failure and is a treatment rather than a risk. Structured rehabilitation improves exercise capacity, quality of life and hospitalisation rates, and is offered after an admission rather than only after myocardial infarction.6
Sleep, mood and vaccination
Sleep-disordered breathing is common and worsens cardiac outcomes; orthopnoea often requires sleeping propped up. Depression and anxiety are frequent after a frightening episode and predict poorer adherence and outcomes. Influenza, pneumococcal and COVID-19 vaccination reduce the infections that precipitate decompensation.
Prognosis
With prompt emergency treatment most people survive the acute episode, and the immediate response to positive pressure and vasodilatation is often dramatic. But an episode of acute pulmonary oedema is a marker of significant underlying heart disease, and the outlook thereafter reflects that: readmission and mortality over the following twelve months are substantial, comparable to many cancers, and higher where the precipitant is myocardial infarction or where therapy is not optimised afterwards. The prognosis is meaningfully modifiable by guideline-directed therapy at target dose, treatment of the precipitant, cardiac rehabilitation and structured follow-up — which makes the weeks after discharge the most important part of the episode.
Role of the physiotherapist
In the acute setting, the physiotherapy contribution begins with positioning — sitting the patient fully upright with legs dependent measurably reduces the work of breathing and is often the first effective intervention delivered. Physiotherapists are frequently involved in setting up and titrating CPAP or bilevel ventilation, in mask fit and tolerance, and in coaching a frightened, air-hungry patient to work with the machine rather than against it, which is what determines whether non-invasive ventilation succeeds. Breathing control and reassurance reduce the sympathetic drive that is worsening the underlying problem. Airway clearance techniques have no role here — the fluid is not sputum, and manual techniques achieve nothing.
As the patient stabilises, early mobilisation prevents the deconditioning and delirium of bed rest, with careful monitoring of heart rate, blood pressure, saturation and symptoms during progression.
Afterwards, the physiotherapist has a central role in heart failure rehabilitation. Exercise-based cardiac rehabilitation in heart failure improves health-related quality of life and reduces heart failure hospitalisations,7 and physiotherapist-delivered rehabilitation begun early after an admission improves physical function in frail older patients.6 The programme combines supervised aerobic and resistance training, education on weight and fluid monitoring, symptom recognition and action-plan use, pacing and energy conservation, and inspiratory muscle training in selected patients with inspiratory weakness. Because physiotherapists see these patients repeatedly over weeks, they are frequently the first to detect the rising weight, the new orthopnoea or the falling exercise tolerance that signals the next episode — and escalating that promptly is as valuable as anything done in the gym.
Part 1 · References
- Ware LB, Matthay MA. Acute pulmonary edema. N Engl J Med 2005;353(26):2788–2796.
- McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42(36):3599–3726.
- Berbenetz N, Wang Y, Brown J, et al. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database Syst Rev 2019;(4):CD005351.
- Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J. Noninvasive ventilation in acute cardiogenic pulmonary edema (3CPO). N Engl J Med 2008;359(2):142–151.
- Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017;50(2):1602426.
- Kitzman DW, Whellan DJ, Duncan P, et al. Physical rehabilitation for older patients hospitalized for heart failure (REHAB-HF). N Engl J Med 2021;385(3):203–216.
- Long L, Mordi IR, Bridges C, et al. Exercise-based cardiac rehabilitation for adults with heart failure. Cochrane Database Syst Rev 2019;(1):CD003331.
References are numbered in citation order (Vancouver/BMJ style) and were current at the time of writing. Guidelines are living documents — verify against the latest version before clinical use.
Supervised exercise, breathing technique and self-management education are the mainstay of cardiorespiratory physiotherapy for this condition.
Clinical evidence
Part 1 covers the same condition without the technical detail. What follows is the evidence base behind it, written for clinicians — the literature, the reasoning and the gaps.
For clinicians: this summary supports clinical reasoning and is not a protocol. Check current guidelines and local policy before applying it, and read it alongside the key references and guidelines directory.
Framing. Acute cardiogenic pulmonary oedema is an alveolar-flooding and loading problem, treated with non-invasive positive pressure, vasodilatation and diuresis while the precipitant is found and corrected.1,2 The single most important physiotherapy point is what not to do: the pink frothy fluid is transudated plasma, not sputum, so airway clearance techniques and suction are the wrong tools — positive pressure and positioning are the right ones.
Non-invasive ventilatory support
- CPAP and bilevel NIV reduce mortality and the need for intubation in acute cardiogenic pulmonary oedema in the Cochrane review, and are recommended by ERS/ATS guidance.3,4
- The large 3CPO trial found no mortality difference between CPAP, NIV and standard oxygen therapy, but faster resolution of breathlessness, acidosis and hypercapnia with positive pressure — hence its place as a symptom- and physiology-directed intervention.5
- There is no consistent advantage of bilevel over CPAP in this setting; choose on hypercapnia, work of breathing and tolerance.3,4
- Mechanism matters: positive intrathoracic pressure reduces venous return and left ventricular afterload, recruits flooded alveoli and unloads the inspiratory muscles — which is why it works within minutes.3
Medical management and precipitants
- Intravenous loop diuretics and vasodilators with treatment of the precipitant — acute coronary syndrome, arrhythmia, uncontrolled hypertension, valve failure, non-adherence, renal decompensation, sepsis — define the medical response.1,2
- Flash pulmonary oedema with severe hypertension or bilateral renal artery stenosis is a specific and recurrent pattern worth recognising.2
- Non-cardiogenic causes exist — re-expansion after large-volume pleural drainage, negative-pressure oedema after upper-airway obstruction, neurogenic and high-altitude oedema — and the management differs.2
- After stabilisation, this is heart failure: REHAB-HF showed early multi-domain rehabilitation during hospitalisation for decompensated heart failure improved physical function in older patients.6
- Exercise-based rehabilitation after discharge reduces heart-failure hospitalisation and improves quality of life.7
Physiotherapy implications
- Sit the patient fully upright, legs dependent, as the first physical action — it reduces preload and improves ventilation–perfusion matching immediately.
- Apply and titrate CPAP or NIV competently where that is within your scope and the local model of care: mask fit and leak, starting pressures, humidification, reassurance, and close monitoring of respiratory rate, work of breathing, saturation and conscious state.3,5
- Do not use airway clearance techniques or suction for the frothy fluid; percussion, vibration and forced expiratory manoeuvres have no target and increase distress and oxygen cost.
- Do not apply positive pressure without checking for contraindications — undrained pneumothorax, vomiting and aspiration risk, facial trauma, obtundation, haemodynamic instability requiring intubation instead.4
- Escalate for intubation criteria: exhaustion, falling respiratory rate with rising effort, deteriorating conscious state, refractory hypoxaemia or shock — NIV is not a substitute for a definitive airway in the deteriorating patient.4
- Once stabilised, start the heart-failure work early: graded mobility, strength, balance and self-monitoring education — daily weights, fluid and salt, symptom action plan.6,7
- Anticipate the medication effects that shape the session: diuretic-driven urgency and dehydration, postural hypotension, electrolyte disturbance and fatigue.
Clinical reasoning
- Fine bilateral crackles with orthopnoea, frothy sputum and raised jugular venous pressure is fluid; coarse localised crackles with purulent sputum is infection. Treating the wrong one wastes critical minutes.
- Ask why it happened. An episode without an identified precipitant will recur, and physiotherapy education on adherence, fluid and salt is part of preventing it.
- Rapid improvement with positive pressure and diuresis confirms the diagnosis; failure to improve should raise sepsis, ARDS, pulmonary embolism or mechanical valve failure.
- Recurrent admissions signal a self-management, medication or social problem more often than a new cardiac lesion.
Evidence gaps
- Optimal CPAP pressure, escalation thresholds and weaning strategy remain largely consensus-driven.3,4
- Who benefits most from bilevel rather than CPAP has not been resolved.5
- Timing of rehabilitation initiation after an acute episode is not defined beyond the REHAB-HF model.6
- Prehospital and community application of non-invasive support is still being evaluated in some systems.
References for the clinical evidence summary
- McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42(36):3599–3726.
- Ware LB, Matthay MA. Acute pulmonary edema. N Engl J Med 2005;353(26):2788–2796.
- Berbenetz N, Wang Y, Brown J, et al. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database Syst Rev 2019;(4):CD005351.
- Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017;50(2):1602426.
- Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J. Noninvasive ventilation in acute cardiogenic pulmonary edema (3CPO). N Engl J Med 2008;359(2):142–151.
- Kitzman DW, Whellan DJ, Duncan P, et al. Physical rehabilitation for older patients hospitalized for heart failure (REHAB-HF). N Engl J Med 2021;385(3):203–216.
- Long L, Mordi IR, Bridges C, et al. Exercise-based cardiac rehabilitation for adults with heart failure. Cochrane Database Syst Rev 2019;(1):CD003331.
Corrections: If something on this page is wrong, out of date or unclear, we want to know. Email reception@inspireclinic.au with the page name and what you believe is incorrect. Substantive corrections are made promptly, and the guide’s version and last-updated date are changed to reflect it.